{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:14:28Z","timestamp":1790738068902,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Transmalaria bloc"},{"name":"\u201cSupporting Postdoctoral Researchers\u201d"},{"DOI":"10.13039\/501100004895","name":"European Social Fund (ESF)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Greek State"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Biochemical Parasitology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.molbiopara.2017.12.003","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T13:18:40Z","timestamp":1514985520000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Distinct effects of HIV protease inhibitors and ERAD inhibitors on zygote to ookinete transition of the malaria parasite"],"prefix":"10.1016","volume":"220","author":[{"given":"Evi","family":"Goulielmaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kaforou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanasis G.","family":"Loukeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Siden-Kiamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Koussis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 2","key":"10.1016\/j.molbiopara.2017.12.003_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S0031182000057334","article-title":"The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic division","volume":"91","author":"Sinden","year":"1985","journal-title":"Parasitology"},{"key":"10.1016\/j.molbiopara.2017.12.003_bib0010","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1146\/annurev.bi.62.070193.002551","article-title":"Structure-based inhibitors of HIV-1 protease","volume":"62","author":"Wlodawer","year":"1993","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.molbiopara.2017.12.003_bib0015","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.50.2.639-648.2006","article-title":"Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria","volume":"50","author":"Andrews","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.molbiopara.2017.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/QAD.0b013e3283621dd4","article-title":"The effect of antiretrovirals on Plasmodium falciparum liver stages","volume":"27","author":"Hobbs","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.molbiopara.2017.12.003_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jit132","article-title":"HIV treatments have malaria gametocyte killing and transmission blocking activity","volume":"208","author":"Hobbs","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.molbiopara.2017.12.003_bib0030","doi-asserted-by":"crossref","first-page":"8076","DOI":"10.1074\/jbc.M109.063388","article-title":"Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.molbiopara.2017.12.003_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exppara.2006.10.006","article-title":"Leishmania mexicana: identification and characterization of an aspartyl proteinase activity","volume":"116","author":"Valdivieso","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"11","key":"10.1016\/j.molbiopara.2017.12.003_bib0040","doi-asserted-by":"crossref","first-page":"e15479","DOI":"10.1371\/journal.pone.0015479","article-title":"The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97\/VCP inhibitory group","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.molbiopara.2017.12.003_bib0045","doi-asserted-by":"crossref","first-page":"e43477","DOI":"10.1371\/journal.pone.0043477","article-title":"Characterization of the ubiquitylating components of the human malaria parasite's protein degradation pathway","volume":"7","author":"Chung","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.molbiopara.2017.12.003_bib0050","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1462-5822.2004.00394.x","article-title":"Real-time, in vivo analysis of malaria ookinete locomotion and mosquito midgut invasion","volume":"6","author":"Vlachou","year":"2004","journal-title":"Cell. Microbiol."},{"issue":"9","key":"10.1016\/j.molbiopara.2017.12.003_bib0055","doi-asserted-by":"crossref","first-page":"e74415","DOI":"10.1371\/journal.pone.0074415","article-title":"Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells","volume":"8","author":"Auner","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.molbiopara.2017.12.003_bib0060","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1128\/AAC.00022-06","article-title":"Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin","volume":"50","author":"Parikh","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.molbiopara.2017.12.003_bib0065","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1128\/AAC.00899-15","article-title":"The glucose transporter PfHT1 is an antimalarial target of the HIV protease inhibitor lopinavir","volume":"59","author":"Kraft","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.molbiopara.2017.12.003_bib0070","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.00166-12","article-title":"Saquinavir inhibits the malaria parasite's chloroquine resistance transporter","volume":"56","author":"Martin","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"52","key":"10.1016\/j.molbiopara.2017.12.003_bib0075","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.1073\/pnas.1216016110","article-title":"Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design","volume":"109","author":"Harbut","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.molbiopara.2017.12.003_bib0080","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ijc.30529","article-title":"HIV-protease inhibitors for the treatment of cancer: repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?","volume":"140","author":"Maksimovic-Ivanic","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.molbiopara.2017.12.003_bib0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCO.0b013e328363dfee","article-title":"Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention","volume":"25","author":"Gantt","year":"2013","journal-title":"Curr. Opin. Oncol."},{"issue":"1","key":"10.1016\/j.molbiopara.2017.12.003_bib0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chom.2012.05.014","article-title":"A Plasmodium calcium-dependent protein kinase controls zygote development and transmission by translationally activating repressed mRNAs","volume":"12","author":"Sebastian","year":"2012","journal-title":"Cell Host Microb."},{"issue":"6","key":"10.1016\/j.molbiopara.2017.12.003_bib0095","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI61822","article-title":"Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors","volume":"122","author":"Ojo","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.molbiopara.2017.12.003_bib0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/fmb.14.30","article-title":"Antimalarial drug delivery to the mosquito: an option worth exploring?","volume":"9","author":"Paaijmans","year":"2014","journal-title":"Future Microbiol."},{"issue":"2","key":"10.1016\/j.molbiopara.2017.12.003_bib0105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nano.2016.09.010","article-title":"Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery","volume":"13","author":"Marques","year":"2017","journal-title":"Nanomedicine"}],"container-title":["Molecular and Biochemical Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685117301652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166685117301652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T19:21:38Z","timestamp":1535138498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166685117301652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"alternative-id":["S0166685117301652"],"URL":"https:\/\/doi.org\/10.1016\/j.molbiopara.2017.12.003","relation":{},"ISSN":["0166-6851"],"issn-type":[{"value":"0166-6851","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct effects of HIV protease inhibitors and ERAD inhibitors on zygote to ookinete transition of the malaria parasite","name":"articletitle","label":"Article Title"},{"value":"Molecular and Biochemical Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molbiopara.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}